These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

129 related items for PubMed ID: 23500606

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Erythrocytes' antioxidative capacity as a potential marker of oxidative stress intensity in neuroinflammation.
    Ljubisavljevic S, Stojanovic I, Cvetkovic T, Vojinovic S, Stojanov D, Stojanovic D, Stefanovic N, Pavlovic D.
    J Neurol Sci; 2014 Feb 15; 337(1-2):8-13. PubMed ID: 24269090
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. The cerebrospinal fluid values of advanced oxidation protein products and total thiol content in patients with amyotrophic lateral sclerosis.
    Djordjevic G, Ljubisavljevic S, Sretenovic S, Kocic G, Stojanovic I, Stojanovic S.
    Clin Neurol Neurosurg; 2017 Dec 15; 163():33-38. PubMed ID: 29055222
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Serum and cerebrospinal fluid prolactin levels in male and female patients with clinically-isolated syndrome or relapsing-remitting multiple sclerosis.
    Markianos M, Koutsis G, Evangelopoulos ME, Mandellos D, Sfagos C.
    J Neuroendocrinol; 2010 Jun 15; 22(6):503-8. PubMed ID: 20236233
    [Abstract] [Full Text] [Related]

  • 7. Histogram analysis of diffusion measures in clinically isolated syndromes and relapsing-remitting multiple sclerosis.
    Yu CS, Lin FC, Liu Y, Duan Y, Lei H, Li KC.
    Eur J Radiol; 2008 Nov 15; 68(2):328-34. PubMed ID: 17928182
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Axonal damage markers in the cerebrospinal fluid of patients with clinically isolated syndrome improve predicting conversion to definite multiple sclerosis.
    Brettschneider J, Petzold A, Junker A, Tumani H.
    Mult Scler; 2006 Apr 15; 12(2):143-8. PubMed ID: 16629417
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Increased plasma levels of advanced oxidation protein products (AOPP) as a marker for oxidative stress in patients with active ulcerative colitis.
    Alagozlu H, Gorgul A, Bilgihan A, Tuncer C, Unal S.
    Clin Res Hepatol Gastroenterol; 2013 Feb 15; 37(1):80-5. PubMed ID: 22572519
    [Abstract] [Full Text] [Related]

  • 13. Advanced oxidation protein products, total thiol levels and total oxidant/antioxidant status in patients with nash.
    Başkol M, Dolbun Seçkin K, Başkol G.
    Turk J Gastroenterol; 2014 Dec 15; 25 Suppl 1():32-7. PubMed ID: 25910362
    [Abstract] [Full Text] [Related]

  • 14. No impact of adult attachment and temperament on clinical variability in patients with clinically isolated syndrome and early multiple sclerosis.
    Fazekas C, Khalil M, Enzinger C, Matzer F, Fuchs S, Fazekas F.
    Clin Neurol Neurosurg; 2013 Mar 15; 115(3):293-7. PubMed ID: 22721773
    [Abstract] [Full Text] [Related]

  • 15. The Validation Study of Neurofilament Heavy Chain and 8-hydroxy-2'-deoxyguanosine as Plasma Biomarkers of Clinical/Paraclinical Activity in First and Relapsing-Remitting Demyelination Acute Attacks.
    Ljubisavljevic S, Stojanovic I, Basic J, Pavlovic DA.
    Neurotox Res; 2016 Oct 15; 30(3):530-8. PubMed ID: 27295058
    [Abstract] [Full Text] [Related]

  • 16. CSF levels of soluble HLA-G and Fas molecules are inversely associated to MRI evidence of disease activity in patients with relapsing-remitting multiple sclerosis.
    Fainardi E, Rizzo R, Melchiorri L, Stignani M, Castellazzi M, Tamborino C, Paolino E, Tola MR, Granieri E, Baricordi OR.
    Mult Scler; 2008 May 15; 14(4):446-54. PubMed ID: 18208868
    [Abstract] [Full Text] [Related]

  • 17. Glutathione homeostasis disruption of erythrocytes, but not glutathione peroxidase activity change, is closely accompanied with neurological and radiological scoring of acute CNS inflammation.
    Ljubisavljevic S, Stojanovic I, Cvetkovic T, Vojinovic S, Stojanov D, Stojanovic D, Bojanic V, Stokanovic D, Pavlovic D.
    Neuroimmunomodulation; 2014 May 15; 21(1):13-20. PubMed ID: 24135853
    [Abstract] [Full Text] [Related]

  • 18. Relation between plasmatic and cerebrospinal fluid oxidative stress biomarkers and intrathecal Ig synthesis in Multiple Sclerosis patients.
    Pasquali L, Pecori C, Chico L, Iudice A, Siciliano G, Bonuccelli U.
    J Neuroimmunol; 2015 Jun 15; 283():39-42. PubMed ID: 26004154
    [Abstract] [Full Text] [Related]

  • 19. Prognostic relevance of the C-X-C motif chemokine ligand 13 and interleukin-8 in predicting the transition from clinically isolated syndrome to multiple sclerosis.
    Klíčová K, Mareš J, Sobek O, Rous Z, Rous M, Raška M, Hartung HP.
    Eur J Neurosci; 2024 Jun 15; 59(11):2955-2966. PubMed ID: 38453679
    [Abstract] [Full Text] [Related]

  • 20. Cerebrospinal fluid and plasma oxidative stress biomarkers in different clinical phenotypes of neuroinflammatory acute attacks. Conceptual accession: from fundamental to clinic.
    Ljubisavljevic S, Stojanovic I, Vojinovic S, Stojanov D, Stojanovic S, Kocic G, Savic D, Cvetkovic T, Pavlovic D.
    Cell Mol Neurobiol; 2013 Aug 15; 33(6):767-77. PubMed ID: 23677512
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.